Forest Labs wins U.S. antitrust approval to buy Furiex

WASHINGTON Fri May 30, 2014 10:10am EDT

WASHINGTON May 30 (Reuters) - Forest Laboratories Inc has won U.S. antitrust approval to buy Furiex Pharmaceuticals Inc, the Federal Trade Commission said on Friday.

Forest had said on April 28 that it would buy Furiex for up to $1.46 billion, adding a promising treatment for irritable bowel syndrome to its gastrointestinal drugs portfolio.

The deal was on a list of approved transactions that the FTC releases several times a week. (Reporting by Diane Bartz)